Dixon Technologies (India) Limited — Quarter ended 31 March 2026; year ended 31 March 2026 (reported in results dated 12 May 2026)
| To | To |
|---|---|
| Secretary | Secretary |
| Listing Department | Listing Department |
| BSE Limited | National Stock Exchange of India Limited |
| Department of Corporate Services | Exchange Plaza, Bandra Kurla Complex |
| Phiroze Jeejeebhoy Towers, | |
| Dalal Street, Mumbai – 400 001 | Mumbai – 400 051 |
| Scrip Code – 540699 | Scrip Code- DIXON |
| ISIN: INE935N01020 | ISIN: INE935N01020 |
| Particulars | Quarter ended 31.03.2026 | Financial year ended 31.03.2026 | ||
|---|---|---|---|---|
| Amount (In Rs. Crores) | Up/ Down ( ↑/↓) | Amount (In Rs. Crores) | Up/Down ( ↑/↓) | |
| Revenue from Operations (including other income) | 10,595 | 3% ↑ | 49,586 | 28% ↑ |
| EBIDTA | 493 | 9% ↑ | 2,580 | 69% ↑ |
| PBT | 370 | 36% ↓ | 2,071 | 32% ↑ |
| PAT | 298 | 36% ↓ | 1,644 | 33% ↑ |
| S. No. | Particulars | Description |
|---|---|---|
| 1 | Brief details of options granted | The Nomination and Remuneration Committee (“Committee”) has approved the grant of 16,155 number of stock options to the employees of the Company, its Subsidiary company(ies) and Joint Venture Company(ies) from time to time in one or more tranches. |
| 2 | Whether the scheme is in terms of SEBI (SBEB) Regulations, 2021 (if applicable) | Yes |
| 3 | Total number of shares covered by these options | 16,155 equity shares (each stock option is convertible into one equity share) of face value of Rs. 2/- each of the Company. |
| 4 | Pricing formula | The Exercise Price is based on the Market Price of the equity shares of the Company which means the latest closing price on a recognized stock exchange on which the shares of the Company are listed on the date immediately prior to the date of meeting of the Committee. As the shares of the Company are listed on more than one Stock Exchange, the price of the Stock Exchange, where there is the highest trading volume during the aforesaid period, has been considered. The Committee has the power to provide suitable discount or charge premium on the price as arrived above. However, in any case, the discount on grant price of the stock options shall not be more than 15% of the market price of the shares of the Company on a recognized stock exchange on which the shares of the Company are listed on the date immediately prior to the date of meeting of Committee on which grant is to be made. |
| 5 | Options vested | Nil |
| 6 | Time within which option may be exercised | The said options shall be exercised within a period of one year from the date of last vesting. |
| 7 | Options exercised | Not Applicable, as this outcome is pertaining to Grant of Options under DIXON ESOP – 2023. |
| 8 | Money realized by exercise of options | Not Applicable, as this outcome is pertaining to Grant of Options under DIXON ESOP – 2023. |
| 9 | The total number of shares arising as a result of exercise of option | 16,155 Equity Shares of face value Rs. 2/ – each will arise deeming all granted options are vested and exercised. |
| 10 | Options lapsed | Not Applicable |
| 11 | Variation of terms of options | Not Applicable |
| 12 | Brief details of significant terms | The grant of stock options is based on the eligibility criteria as decided by the Committee. The Grant of an Option shall entitle the holder to acquire one Equity share in the Company, upon payment of Exercise Price. The options granted under the scheme will vest over a period of Three years from the date of grant of options. Further the Options vested may be exercised by the Option Grantee within a maximum period of One Year from the date of last vesting of Options. The exercise price shall be based on the market price of the Company which shall mean the latest closing price on the recognized stock exchange on which the shares of the Company are listed on the date immediately prior to the date of meeting of Committee on which grant is to be made. As the shares of the Company are listed on more than one stock exchange, the closing price on the stock exchange having higher trading volume shall be considered as the market price. In any case, the exercise price shall not go below the face value of Equity shares of the Company. |
| 13 | Subsequent changes or cancellation or exercise of such options | Not Applicable |
| 14 | Diluted earnings per share pursuant to issue of equity shares on exercise of options | Not Applicable |
| S. No. | Particulars | Quarter ended 31-Mar-26 | Quarter ended 31-Dec-25 | Quarter ended 31-Mar-25 | Year ended 31-Mar-26 | Year ended 31-Mar-25 |
|---|---|---|---|---|---|---|
| Unaudited (refer note 12) | Unaudited (refer note 12) | Audited | Audited | Audited | ||
| 1 | Revenue from operations | 86,132 | 79,250 | 1,08,567 | 3,93,048 | 5,40,090 |
| 2 | Other income | 8,129 | 19,233 | 4,114 | 80,198 | 6,647 |
| 3 | Total income (1+2) | 94,261 | 98,483 | 1,12,681 | 4,73,246 | 5,46,737 |
| 4 | Expenses | |||||
| a) Cost of materials consumed | 78,891 | 54,940 | 85,364 | 3,29,476 | 4,58,911 | |
| b) Changes in inventories of finished goods, work-in-progress and stock-in-trade | (7,302) | 8,777 | 5,310 | (5,012) | 820 | |
| c) Employee benefits expense | 5,963 | 5,347 | 4,896 | 24,028 | 26,442 | |
| d) Finance costs | 699 | 1,905 | 1,515 | 5,427 | 5,303 | |
| e) Depreciation and amortisation expense | 1,690 | 1,648 | 1,997 | 6,989 | 7,065 | |
| f) Other expenses | 5,618 | 4,607 | 5,869 | 23,521 | 29,258 | |
| Total expenses | 85,559 | 77,224 | 1,04,951 | 3,84,429 | 5,27,799 | |
| 5 | Profit before exceptional item and tax (3-4) | 8,702 | 21,259 | 7,730 | 88,817 | 18,938 |
| 6 | Exceptional items (refer note 4) | – | – | 25,037 | – | 48,950 |
| 7 | Profit before tax (5+6) | 8,702 | 21,259 | 32,767 | 88,817 | 67,888 |
| 8 | Tax expenses (Net) | |||||
| a) Current tax | 8,921 | 1,124 | 801 | 12,646 | 4,061 | |
| b) Deferred tax | (7,838) | 1,427 | 4,111 | 398 | 7,211 | |
| c) Income tax related to earlier years | (171) | – | – | (171) | 26 | |
| Total tax expenses | 912 | 2,551 | 4,912 | 12,873 | 11,298 | |
| 9 | Net Profit for the period/year (7-8) | 7,790 | 18,708 | 27,855 | 75,944 | 56,590 |
| 10 | Other Comprehensive Income (‘OCI’) | |||||
| a) Items that will not be reclassified to Profit or Loss | 57 | (15) | (159) | 12 | (59) | |
| b) Income tax relating to items that will not be reclassified to profit or loss | (14) | 4 | 42 | (3) | 13 | |
| Other Comprehensive Income | 43 | (11) | (117) | 9 | (46) | |
| 11 | Total Comprehensive Income (9+10) | 7,833 | 18,697 | 27,738 | 75,953 | 56,544 |
| 12 | Paid-up equity share capital (Face value per share Rs. 2/-) | 1,216 | 1,214 | 1,205 | 1,216 | 1,205 |
| 13 | Other equity excluding revaluation reserve | – | – | – | 3,22,685 | 2,17,072 |
| 14 | Earnings per share (EPS) | |||||
| (Nominal value of Rs. 2/- each) (not annualised) | ||||||
| (a) Basic (Rs.) | 12.87 | 30.96 | 46.49 | 125.44 | 94.44 | |
| (b) Diluted (Rs.) | 12.76 | 30.71 | 45.78 | 124.41 | 93.01 |
| Particulars | As at 31-Mar-2026 (Audited) | As at 31-Mar-2025 (Audited) |
|---|---|---|
| ASSETS | ||
| Non-current assets | ||
| a. Property, plant and equipment | 56,895 | 57,372 |
| b. Capital work-in-progress | 36,670 | 17,418 |
| c. Other intangible assets | 993 | 1,044 |
| d. Right of use assets | 21,737 | 25,798 |
| e. Financial assets: | ||
| i. Investments | 1,90,688 | 1,08,605 |
| ii. Loans | 1,495 | 24,182 |
| iii. Other financial assets | 1,924 | 2,288 |
| f. Other non-current assets | 812 | 918 |
| Total Non-current assets | 3,11,214 | 2,37,625 |
| Current assets | ||
| a. Inventories | 47,634 | 38,418 |
| b. Financial assets: | ||
| i. Trade receivables | 55,515 | 60,763 |
| ii. Cash and cash equivalents | 2,163 | 3,753 |
| iii. Bank balances other than cash and cash equivalents | 36 | 151 |
| iv. Loans | 2,938 | 4 |
| v. Other financial assets | 2,403 | 1,310 |
| c. Current tax assets (net) | 2,110 | 870 |
| d. Other current assets | 6,869 | 5,147 |
| Total Current assets | 1,19,668 | 1,10,416 |
| TOTAL ASSETS | 4,30,882 | 3,48,041 |
| EQUITY AND LIABILITIES | ||
| Equity | ||
| a. Equity share capital | 1,216 | 1,205 |
| b. Other equity | 3,22,685 | 2,17,072 |
| TOTAL EQUITY | 3,23,901 | 2,18,277 |
| Liabilities | ||
| Non-current liabilities | ||
| a. Financial liabilities: | ||
| i. Borrowings | – | 2,700 |
| ii. Lease liabilities | 7,541 | 11,546 |
| b. Provisions | 184 | 487 |
| c. Deferred tax liabilities (Net) | 9,066 | 8,665 |
| d. Other non-current liabilities | 2,973 | 1,483 |
| Total Non-current liabilities | 19,764 | 24,881 |
| Current liabilities | ||
| a. Financial liabilities: | ||
| i. Borrowings | 17,220 | 14,966 |
| ii. Lease liabilities | 979 | 1,042 |
| iii. Trade payables – Total outstanding dues of micro and small enterprises | 4,092 | 2,954 |
| iii. Trade payables – Total outstanding dues of other than micro and small Enterprises | 58,372 | 73,801 |
| iv. Other financial liabilities | 3,777 | 5,227 |
| b. Other current liabilities | 2,518 | 6,382 |
| c. Provisions | 259 | 511 |
| Total Current liabilities | 87,217 | 1,04,883 |
| TOTAL LIABILITIES | 1,06,981 | 1,29,764 |
| TOTAL EQUITY AND LIABILITIES | 4,30,882 | 3,48,041 |
| Particulars | Year ended 31-Mar-2026 (Audited) | Year ended 31-Mar-2025 (Audited) |
|---|---|---|
| A. Cash flow from operating activities | ||
| Profit before tax | 88,817 | 67,888 |
| Adjustments for : | ||
| Depreciation and amortisation expense | 6,989 | 7,065 |
| Finance costs | 5,427 | 5,303 |
| Unrealised foreign exchange (gain)/loss (net) | 49 | – |
| Interest income | (1,466) | (2,492) |
| Dividend income | (7,074) | (2,900) |
| (Profit)/Loss on lease modification/closure | (429) | (989) |
| (Profit)/loss on sale of investment in mutual funds | (28) | (1) |
| (Profit)/Loss on sale of property, plant and equipment | (43) | (215) |
| (Profit)/Loss on disinvestment of shares in joint venture | – | (48,950) |
| Gain/(loss) on sale/fair value of equity investment | (68,955) | – |
| Gain on sale of undertaking under slump sale | (2,188) | – |
| (Profit)/Loss on disposal of investments | – | 10 |
| Provision for doubtful debts / loans and advances written back | 825 | 450 |
| Share based payments to employees | 4,678 | 6,020 |
| 26,602 | 26,602 | 31,189 |
| Changes in working capital | ||
| Adjustments for (increase) / decrease in operating assets: | ||
| Inventories | (14,185) | 591 |
| Trade receivables | (8,105) | 32,060 |
| Other financial assets – non-current | 279 | (83) |
| Other financial assets – current | (1,128) | (840) |
| Other current assets | (1,764) | (1,032) |
| Adjustments for increase / (decrease) in operating liabilities: | ||
| Trade payables | 3,636 | (30,890) |
| Provisions – non-current | (291) | (830) |
| Provisions – current | 392 | 176 |
| Other liabilities – non-current | 1,490 | – |
| Other liabilities – current | (3,864) | 421 |
| Other current financial liabilities | 296 | 2,320 |
| Cash generated from operating activities | 3,358 | 33,082 |
| Income tax paid (net) | (13,715) | (5,223) |
| Net cash generated from/ (used in) operating activities | (10,357) | 27,859 |
| B. Cash flow from investing activities | ||
| Capital expenditure on property, plant and equipment and intangible assets including capital work in progress | (30,683) | (19,036) |
| Sale proceeds of property, plant and equipment | 557 | 1,270 |
| Purchase of investments in subsidiaries | (67,424) | (47,240) |
| Investment in equity shares of other Company | – | (24,863) |
| Proceeds from sale/disinvestment of investment in joint venture company | – | 24,863 |
| Loan given | (2,934) | – |
| Repayment of loan given | 22,687 | 21,391 |
| Sale of investment in equity share | 65,826 | – |
| Purchase of investment in mutual fund | (70,505) | (6,500 |